Skip to main content
. 2022 Mar 31;24(5):855–860. doi: 10.1002/ejhf.2490

Figure 3.

EJHF-2490-FIG-0003-c

Comparison between the observed and forecasted sacubitril/valsartan new prescriptions between March and December 2020.